Company Filing History:
3 out of 709 
1 out of 75 
Years Active: 2009-2024
Title: Michael Stürzl - A Pioneer in Colorectal Cancer Detection
Introduction
Michael Stürzl, an innovative inventor based in Erlangen, Germany, has made significant contributions to the medical field, particularly in the detection of colorectal cancer. With a total of four patents to his name, his work has been pivotal in advancing diagnostic methods that aid in early cancer detection and treatment.
Latest Patents
Among his latest inventions is a groundbreaking method for detecting an increased risk or incidence of colorectal cancer. This invention focuses on the development of methods and products that not only detect colorectal cancer but also determine the probability, risk, or incidence of the disease and its metastasis. The invention involves assessing the levels of expression of specific biomarkers, such as COL10A1 or MMP11, from tissue samples of individuals who are currently diagnosed with cancer, have been previously diagnosed, or are under diagnostic evaluation for suspected cases of cancer.
Career Highlights
Michael has worked with esteemed organizations like Siemens Healthcare Diagnostics GmbH and Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt. His experience in these reputable companies has enhanced his expertise in healthcare diagnostics and medical research.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Roland S. Croner and Andreas Konrad. These partnerships have contributed to the robustness of his research and developments in the field of cancer detection.
Conclusion
Michael Stürzl's innovative approaches and significant patents demonstrate his commitment to improving cancer detection methods. His contributions are invaluable to the medical community and play a crucial role in enhancing patient outcomes through early diagnosis and intervention.